Clinical Trial Update: A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 PK/PD study update for Polyethylene Glycol Loxenatide in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Polyethylene Glycol Loxenatide (polyethylene glycol loxenatide)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED